Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

26.04
Delayed Data
As of Mar 27
 +0.53 / +2.08%
Today’s Change
19.10
Today|||52-Week Range
47.65
+24.36%
Year-to-Date

Today’s Trading

Previous close25.51
Today’s open25.51
Day’s range25.42 - 26.39
Volume305,518
Average volume (3 months)649,840
Market cap$728.0M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+38.36%
Earnings growth (this year)-11.48%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+226.23%
P/E ratioNM
Price/Sales3.84
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.27-1.22%
AERIAerie Pharmaceutical...+0.42+1.38%
ANIPANI Pharmaceuticals ...+1.55+2.57%
IMGNImmunoGen Inc+0.27+3.38%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateApril 28, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$158.4M
Annual profit (last year)-$39.4M
Net profit margin-24.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc D. Beer
Chief Operating Officer
Craig E. Fraser
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account